IL169124A0 - Preparation and administration of hybrid cell vaccines for the prevention of cancer - Google Patents

Preparation and administration of hybrid cell vaccines for the prevention of cancer

Info

Publication number
IL169124A0
IL169124A0 IL169124A IL16912405A IL169124A0 IL 169124 A0 IL169124 A0 IL 169124A0 IL 169124 A IL169124 A IL 169124A IL 16912405 A IL16912405 A IL 16912405A IL 169124 A0 IL169124 A0 IL 169124A0
Authority
IL
Israel
Prior art keywords
cancer
administration
prevention
preparation
hybrid cell
Prior art date
Application number
IL169124A
Other languages
English (en)
Original Assignee
Tsuneya Ohno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsuneya Ohno filed Critical Tsuneya Ohno
Publication of IL169124A0 publication Critical patent/IL169124A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/35—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL169124A 2002-12-16 2005-06-09 Preparation and administration of hybrid cell vaccines for the prevention of cancer IL169124A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/320,779 US20040115224A1 (en) 2002-12-16 2002-12-16 Preparation and administration of hybrid cell vaccines for the prevention of cancer
PCT/US2003/040284 WO2004057968A1 (en) 2002-12-16 2003-12-16 Preparation and administration of hybrid cell vaccines for the prevention of cancer

Publications (1)

Publication Number Publication Date
IL169124A0 true IL169124A0 (en) 2007-07-04

Family

ID=32506941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169124A IL169124A0 (en) 2002-12-16 2005-06-09 Preparation and administration of hybrid cell vaccines for the prevention of cancer

Country Status (7)

Country Link
US (1) US20040115224A1 (enExample)
EP (1) EP1583424A4 (enExample)
JP (1) JP2006509830A (enExample)
AU (1) AU2003301023A1 (enExample)
CA (1) CA2508209A1 (enExample)
IL (1) IL169124A0 (enExample)
WO (1) WO2004057968A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155514A0 (en) * 2000-10-20 2003-11-23 Tsuneya Ohno Fusion cells and cytokine compositions for treatment of disease
US20050180951A1 (en) * 2004-02-12 2005-08-18 Tsuneya Ohno Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
JP2007528375A (ja) * 2004-03-02 2007-10-11 典也 大野 癌の治療および予防用雑種細胞ワクチンの方法および組成物
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
CA2676808C (en) * 2007-04-27 2016-08-02 Bavarian Nordic A/S Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
US9695397B2 (en) * 2008-10-01 2017-07-04 Immunovative Therapies Ltd. Th1 vaccination priming for active immunotherapy
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
JP2022542745A (ja) * 2019-05-27 2022-10-07 錦高キャピタル株式会社 樹状細胞ベースの癌ワクチン及びその調製方法
US20240002798A1 (en) * 2020-11-17 2024-01-04 Research & Business Foundation Sungkyunkwan University Method for preparing immunogenicity-enhanced cd103+ fcgr3+ dendritic cell by treatment with interleukin-33 and pharmaceutical composition comprising same dendritic cell for cancer immunotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85919A1 (fr) * 1984-06-07 1986-01-14 Marginvest Sa Holding Procede de preparation d'un agent absorbant et adsorbant,et agent absorbant et adsorbant ainsi obtenu
US5772995A (en) * 1994-07-18 1998-06-30 Sidney Kimmel Cancer Center Compositions and methods for enhanced tumor cell immunity in vivo
US20020041868A1 (en) * 1997-04-15 2002-04-11 Charles Nicolette Cell fusions and methods of making and using the same
DE69839215T2 (de) * 1997-04-15 2009-03-19 Dana-Farber Cancer Institute, Inc., Boston Dendritische zellhybride
JP5054875B2 (ja) * 2000-02-11 2012-10-24 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 樹状細胞ハイブリッドによって活性化される細胞傷害性ｔリンパ球
IL155514A0 (en) * 2000-10-20 2003-11-23 Tsuneya Ohno Fusion cells and cytokine compositions for treatment of disease

Also Published As

Publication number Publication date
WO2004057968A1 (en) 2004-07-15
CA2508209A1 (en) 2004-07-15
US20040115224A1 (en) 2004-06-17
EP1583424A4 (en) 2006-12-27
JP2006509830A (ja) 2006-03-23
EP1583424A1 (en) 2005-10-12
AU2003301023A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU2002952811A0 (en) Hyperbaric therapy capsule
PL377854A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
ZA200410229B (en) Administration of therapeutic viruses
IL164463A (en) Use of osteoprotegerin in the preparation of medicaments
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
IL169124A0 (en) Preparation and administration of hybrid cell vaccines for the prevention of cancer
IL144845A0 (en) Vaccines and gene therapy compositions and methods of making and using the same
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
IL177843A0 (en) Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
GB0124071D0 (en) Improvement in the administration of high boiling point aneasthetics
AU2003296385A8 (en) Therapeutic single dose gas administration system
AU2003300772A1 (en) Preventive and therapeutic aids vaccines
AU2002354943A1 (en) Haptenizing cancer cell components for the preparation of cancer vaccines
EP1221945A4 (en) METHOD AND PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS FOR THE ADMINISTRATION OF ADENOSINE
GB2394659B (en) Therapeutic and prophylactic preparations
AU2001280443A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
GB0201607D0 (en) Formulation for the administration of medicinal substances
AU2002328568A1 (en) External preparation for the skin and copolymer to be used therein
AU2001291256A1 (en) Methods and compositions for the identification, assessment and therapy of human cancers
GB0317345D0 (en) Formulation for the administration of medicinal substances
IL160412A0 (en) Methods and pharmaceutical compositions for immune deception, particularly in the treatment of cancer
IL139082A0 (en) Pharmaceutical preparation useful for the prevention of cancer